Stay updated with breaking news from Stephanie may. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
More unaccompanied minor refugees are arriving in the Rhein-Sieg-Kreis again, and places for them are now scarce. Many municipalities are already having difficulties accommodating the young people.
In an oral presentation at ESMO 2022, data from the GDFATHER-1 trial showed that treatment with visugromab and the anti-PD-1 inhibitor nivolumab resulted in excellent tolerability and significant anti-tumor
The seesaw of water quality standards for Washington state has tilted back toward more protective pollutant limits from the Environmental Protection Agency. Several years ago,...
AUDI Brussels CEO Volker Germann and Volkswagen CV's Member of the Board of Management Dr Astrid Fontaine are TWO of the speakers confirmed for the June Summit
Stephanie May lives an active lifestyle. She's a black belt in karate and plays the piano. So when she started having some stomach problems she didn't think much of it. Luckily, she listened to her body and went to the hospital. It was a decision that would end up saving her life.
CatalYm receives International Nonproprietary Name (INN) visugromab for CTL-002 as approved by the World Health Organization CatalYm today announced treatment of the first patients in a series of
Skoda's Maren Graef To Speak At The Women Automotive Network's Spring Meetup - Energy Industry Today einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.
Agomab Therapeutics NV ('Agomab') today announced that Tim Knotnerus, Chief Executive Officer, will present a company overview and update at the virtual 40th Annual J.P. Morgan Healthcare Conference
Agomab Therapeutics NV ('Agomab') today announced the expansion of its team with two key hires: Reginald Brys will join as Head of Research and Maria Nichol will become Head of Intellectual Property.